Diana Lightfoot
Physician Assistant · Grand Rapids, MINPI 1053414128
Payments from drug & device makers
Across 272 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$681
- AstraZeneca$615
- AbbVie$488
- Lilly USA, LLC$248
- Boehringer Ingelheim$210
- Johnson & Johnson$176
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,172100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $681 |
| AstraZeneca | 34 | $615 |
| AbbVie(2 entities) | 33 | $488 |
| Lilly USA, LLC | 21 | $248 |
| Boehringer Ingelheim | 13 | $210 |
| Johnson & Johnson | 12 | $176 |
| GSK | 12 | $159 |
| Astellas Pharma US Inc | 7 | $120 |
| Neurelis, Inc. | 6 | $101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $101 |
| Amgen | 5 | $97 |
| Pfizer | 5 | $97 |
| Biohaven Pharmaceuticals, Inc. | 6 | $88 |
| Philips North America LLC | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $74 |
| Electromed, Inc. | 5 | $74 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
| Amarin Pharma, Inc. | 4 | $63 |
| Bayer | 3 | $63 |
| UCB, Inc. | 4 | $61 |
| Merck | 4 | $52 |
| Dexcom, Inc. | 3 | $51 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Insulet Corporation | 2 | $26 |
| Eisai Inc. | 1 | $25 |
| Endogastric Solutions, Inc | 2 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Bardy Diagnostics, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$107
How this compares
$4,185 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 31 | $25,784 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $18,131 |
| FarxigaDapagliflozin Propanediol | 26 | $15,324 |
| TrulicityDulaglutide | 11 | $9,511 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 11 | $9,002 |
| MyrbetriqMirabegron | 12 | $5,281 |
| Atorvastatin Calcium | 110 | $2,067 |
| Rosuvastatin Calcium | 76 | $1,383 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $1,055 |
| Omeprazole | 52 | $1,012 |
| Levothyroxine Sodium | 65 | $873 |
| Losartan Potassium | 34 | $573 |
| Lisinopril | 46 | $566 |
| Valsartan | 20 | $526 |
| Pantoprazole Sodium | 28 | $497 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $210 | $25,78431 claims |
| GSKTrelegy Ellipta | $159 | $18,13125 claims |
| AstraZenecaFarxiga | $615 | $15,32426 claims |
| Lilly USA, LLCTrulicity | $248 | $9,51111 claims |
| Astellas Pharma US IncMyrbetriq | $120 | $5,28112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Grand Rapids
- Erin van DykeGrand Rapids$346K
- Melissa JosephGrand Rapids$82K
- Matthew SchultzGrand Rapids$49K
- Shannon ToddGrand Rapids$32K
- Patrick HandlinGrand Rapids$28K
- John MulderGrand Rapids$27K
- Ginger BiesbrockGrand Rapids$25K
- Matthew ZoetemanGrand Rapids$23K
- Aaron ZarnoskyGrand Rapids$22K
- Sarang PatelRoyal Oak$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.